Protection against Marek's disease by a fowlpox virus recombinant expressing the glycoprotein B of Marek's disease virus.
AUTOR(ES)
Nazerian, K
RESUMO
Fowlpox virus (FPV) recombinants expressing the glycoprotein B and the phosphorylated protein (pp38) of the GA strain of Marek's disease virus (MDV) were assayed for their ability to protect chickens against challenge with virulent MDV. The recombinant FPV expressing the glycoprotein B gene elicited neutralizing antibodies against MDV, significantly reduced the level of cell-associated viremia, and, similar to the conventional herpesvirus of turkeys, protected chickens against challenge with the GA strain and the highly virulent RB1B and Md5 strains of MDV. The recombinant FPV expressing the pp38 gene failed to either elicit neutralizing antibodies against MDV or protect the vaccinated chickens against challenge with MDV.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=240864Documentos Relacionados
- Recombinant fowlpox viruses expressing the glycoprotein B homolog and the pp38 gene of Marek's disease virus.
- Protection against Marek's disease-derived tumor transplants by the nononcogenic SB-1 strain of Marek's disease virus.
- Depression of vaccinal immunity to Marek's disease by infection with reticuloendotheliosis virus.
- Synthesis and processing of the Marek's disease herpesvirus B antigen glycoprotein complex.
- Efficiency of Commercial Air Filters Against Marek's Disease Virus
